Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only'. Together they form a unique fingerprint.